Sherene Loi, MD
@LoiSher
Followers
4K
Following
3K
Statuses
803
Professor, Medical Oncologist, #LoiLab @PeterMacCC @UniMelb @NBCFAus Endowed Chair, #IBSCG cochair @etop_ibcsg, @TILsWorkgroup cofounder; own views
Melbourne, Australia
Joined August 2011
Our latest review is out now on targeting #BreastCancer #Immunity #tme #trm #CancerResearch many thanks to @NatureRevCancer
@PeterMacCC @PeterMacRes @TILsWorkGroup
Towards targeting the breast cancer immune microenvironment
0
11
43
A huge thank you to all the trial teams globally, patients & the families, BMS, and my fellow steering committee members
0
0
2
Finally, these findings along with KN756 will change the way we think about HR positive #breastcancer & T cell immune surveillance in BC
0
0
1
Our findings revealed that addition of the Nivo led to a significant improvement in PCR
0
0
0
A new subset of HR+ #BreastCancer with #til present can respond to #nivolumab & chemo ➡️ @PeterMacCC @OncoAlert #bcsm
A Peter Mac international clinical trial led by @LoiSher has shown adding #immunotherapy drug nivolumab + chemo before surgery can dramatically improve #breastcancer cure rates. On the front page of today's @theheraldsun or more here:
0
4
14
👏👏👏congrats @IlanaSchlam
Hot off the press “Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges” @SandraSwainMD @LoiSher and Roberto Salgado @DFCI_BreastOnc
0
1
4
Looking fwd to the joint annual meeting of 🇯🇵 #jcog #kbcs 🇰🇷#tibcs 🇹🇼 and @BCTrialsANZ 🇦🇺 in #nagoya #breastcancer trials
0
6
21
2
3
25
RT @PeterMacCC: We are incredibly proud to announce that five Peter Mac researchers have been named in @Clarivate's top 1% most cited resea…
0
2
0
RT @ScienceMagazine: Scientists have identified how the redox sensor #KEAP1 promotes antiviral T cell activation and stem-like T cell respo…
0
17
0
#tils @TILsWorkGroup 10 yrs! 👏👏
The #OncoAlertTopTweet Day TWO #SABCS24 Post by @OncoAlert 🚨Faculty @TanjaSpanic 🇸🇮 10 years later: TILs and lessons learned by Roberto Salgado. My personal take off: there are always more TILs than PDL1 😎 @lab_kok
@matteolambe 🇮🇹 @ErikaHamilton9 🇺🇸 @hoperugo 🇺🇸 @JaniceTNBCmets 🇺🇸 @DrSGraff 🇺🇸 @maryam_lustberg 🇺🇸 @double_whammied 🇺🇸 @Prof_Nadia_H 🇩🇪 @JavierCortesMD 🇪🇸 @raalbany 🇺🇸 @itsnot_pink 🇺🇸 @ElisaAgostinett 🇧🇪 @coffeemommy 🇺🇸 @christeeny513 🇺🇸 @MammaMiaMagazin 🇩🇪 @Icro_Meattini 🇮🇹 @itrisabel 🇪🇸 @E_de_Azambuja 🇧🇪 @aftimosp 🇧🇪 @TanjaSpanic 🇸🇮 @stolaney1 🇺🇸 @curijoey 🇮🇹 @kevinpunie 🇧🇪 @to_be_elizabeth 🇮🇹 @Lucarecco 🇮🇹 @FernandoOnco 🇧🇷 @stage4kelly 🇺🇸 @acampsmalea 🇫🇷 @jamecancerdoc 🇺🇸 @LoiSher 🇦🇺
0
0
3
RT @SABCSSanAntonio: Roberto Salgado, Justin Balko, and Priyanka Sharma (who joined virtually) explored "The Winding Road of Immune Biomark…
0
2
0
RT @oncodaily: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts - @LoiSher
#Cancer #On…
0
1
0
@onder_haka2124 @J_DixonDouglas @GustaveRoussy @PeterMacRes @BCRFcure Obviously this is a complex issue - breast cancer survival as well as lymphopenia per se, and this is discussed.
0
0
2
congrats @StoverLab fantastic collboration with all involved- lets do it again soon #TIL @TILsWorkGroup -- cure #metastaticbreastcancer faster #bcsm
New📰| Association between #TumorInfiltratingLymphocytes and survival in patients with #MetastaticBreastCancer receiving first-line chemotherapy: Analysis of CALGB 40502 from the @StoverLab @elmayermd @AnnPartridgeMD @LoiSher et al. 🔓Read it here: #TILs
1
0
8
RT @LoiSher: join us at @PeterMacCC #melbourne, #australia for the 2nd annual #BreastCancer #medicaloncology #education day Friday Oct 11th…
0
1
0
RT @DrSGraff: A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in @NatureRevCancer by @LoiSher et…
0
73
0